Search Results 241-250 of 13248 for Assay
Natera has developed an assay called Prospera™ to detect the amount of donor-derived cell-free DNA (dd-cfDNA), which is a marker of kidney rejection. A ...
... assay for the sensitive detection of CXCL10 in plasma-derived sEV, and 3) characterization of plasma-derived sEV through assessment of concentration, size ...
This test, also called an alpha-synuclein seed amplification assay, detects Parkinson's disease before symptoms begin. Alpha-synuclein clumps are a hallmark ...
Resultant cell products may be banked and distributed for laboratory studies/in vitro assay development with collaborators enterprise-wide and external partners ...
The assay quantifies the fraction of dd-cfDNA in both unrelated and related ... Application of the assay to clinical samples from heart transplant ...
... assays come to life. “Nationally ... For instance, when the bacteriology laboratory recently developed a broad-range 16s rRNA bacterial detection assay ...
The purpose of this study is to assess the accuracy of DNA marker candidates (individually and in combination) assayed from urine and prostatic fluid ...
Pritt has coordinated the development of real-time polymerase chain reaction (PCR) assays ... She has also developed a multiplex PCR assay for the major human ...
Theel's research focuses on the development and evaluation of serologic assays for the diagnosis of infections caused by: Borrelia burgdorferi; Histoplasma ...
Ceramide testing is a novel assay that can reveal more about heart disease and stroke risk than standard lipid tests.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.